IDEAYA Biosciences (IDYA) Net Income towards Common Stockholders: 2020-2025
Historic Net Income towards Common Stockholders for IDEAYA Biosciences (IDYA) over the last 4 years, with Sep 2025 value amounting to $108.5 million.
- IDEAYA Biosciences' Net Income towards Common Stockholders rose 262.13% to $108.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$167.5 million, marking a year-over-year increase of 25.47%. This contributed to the annual value of -$327.0 million for FY2024, which is 143.23% down from last year.
- Latest data reveals that IDEAYA Biosciences reported Net Income towards Common Stockholders of $108.5 million as of Q3 2025, which was up 175.24% from -$144.1 million recorded in Q4 2024.
- In the past 5 years, IDEAYA Biosciences' Net Income towards Common Stockholders ranged from a high of $108.5 million in Q3 2025 and a low of -$144.1 million during Q4 2024.
- In the last 3 years, IDEAYA Biosciences' Net Income towards Common Stockholders had a median value of -$41.9 million in 2023 and averaged -$39.2 million.
- As far as peak fluctuations go, IDEAYA Biosciences' Net Income towards Common Stockholders crashed by 5,179.70% in 2023, and later skyrocketed by 262.13% in 2025.
- Quarterly analysis of 5 years shows IDEAYA Biosciences' Net Income towards Common Stockholders stood at -$18.4 million in 2021, then tumbled by 43.95% to -$26.4 million in 2022, then plummeted by 58.52% to -$41.9 million in 2023, then slumped by 243.87% to -$144.1 million in 2024, then spiked by 262.13% to $108.5 million in 2025.
- Its last three reported values are $108.5 million in Q3 2025, -$144.1 million for Q4 2024, and -$66.9 million during Q3 2024.